DexCom, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2025: USD 225.20 M

DexCom, Inc. Depreciation And Amortization is USD 225.20 M for the Trailing 12 Months (TTM) ending March 31, 2025, a 14.37% change year over year. Depreciation and amortization are expense that reduces the value of tangible and intangible assets over their useful lives for tax and reporting purposes.
  • DexCom, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 196.90 M, a 22.53% change year over year.
  • DexCom, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 160.70 M, a 36.30% change year over year.
  • DexCom, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 117.90 M, a 57.20% change year over year.
  • DexCom, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 75.00 M, a 44.79% change year over year.
Key Data
Date Depreciation And Amortization Dividends Paid Common Stock Issued Common Stock Repurchased